These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23509323)

  • 1. How can outcomes be improved for older patients with Hodgkin lymphoma?
    Evens AM; Hong F
    J Clin Oncol; 2013 Apr; 31(12):1502-5. PubMed ID: 23509323
    [No Abstract]   [Full Text] [Related]  

  • 2. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
    Canellos GP; Duggan D; Johnson J; Niedzwiecki D
    J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy alone for early-stage Hodgkin's lymphoma.
    Straus DJ
    N Engl J Med; 2012 Feb; 366(5):470-1. PubMed ID: 22149920
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.
    D'Arco AM; Califano C; Barone L; Belsito Petrizzi V; Iovino V; Langella M; Maglione V; Rivellini F; De Lorenzo S
    Br J Haematol; 2015 Nov; 171(4):662-5. PubMed ID: 25873239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.
    Canellos GP
    J Clin Oncol; 2005 Jul; 23(21):4574-6. PubMed ID: 15837972
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversies in the treatment of early-stage Hodgkin's lymphoma.
    Longo DL; Armitage JO
    N Engl J Med; 2015 Apr; 372(17):1667-9. PubMed ID: 25901431
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
    Arakelyan N; Jais JP; Delwail V; Brière J; Moles-Moreau MP; Sénécal D; Berthou C; Desablens B; Colonna P; Andrieu JM;
    Cancer; 2010 Sep; 116(17):4054-62. PubMed ID: 20564152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
    Diehl V
    J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791
    [No Abstract]   [Full Text] [Related]  

  • 10. Hodgkin's lymphoma--the great teacher.
    Connors JM
    N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation in early-stage Hodgkin lymphoma.
    Meyer RM
    Clin Adv Hematol Oncol; 2013 Mar; 11(3):162-89. PubMed ID: 23598983
    [No Abstract]   [Full Text] [Related]  

  • 12. Marathon running during chemotherapy: where are the limits?
    Dimeo FC
    Onkologie; 2011; 34(5):230. PubMed ID: 21577027
    [No Abstract]   [Full Text] [Related]  

  • 13. Marathon run under chemotherapy: is it possible?
    Bernhörster M; Rosenhagen A; Vogt L; Thiel C; Jäger E; Banzer W
    Onkologie; 2011; 34(5):259-61. PubMed ID: 21577032
    [No Abstract]   [Full Text] [Related]  

  • 14. Central nervous system Hodgkin lymphoma developing during systemic chemotherapy.
    Burrows SH; Mannari D
    Br J Haematol; 2016 Jan; 172(2):156. PubMed ID: 26455346
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
    Cencini E; Fabbri A; Bocchia M
    Br J Haematol; 2017 Mar; 176(5):831-833. PubMed ID: 26913966
    [No Abstract]   [Full Text] [Related]  

  • 16. Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma.
    Bond DA; Dotson E; Awan FT; Baiocchi RA; Blum KA; Maddocks K
    Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):e123-e128. PubMed ID: 30594446
    [No Abstract]   [Full Text] [Related]  

  • 17. Vinblastine for elderly and frail patients with Hodgkin lymphoma.
    Meynard L; Galtier J; Favre S; Debus L; Lascaux A; Dilhuydy MS; Gros FX; Sauvezie M; Milpied N; Bouabdallah K; Dimicoli S
    Leuk Lymphoma; 2020 Dec; 61(13):3239-3242. PubMed ID: 32716269
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine Shortage.
    Torka P; Przespolewski E; Evens AM
    JCO Oncol Pract; 2022 Jul; 18(7):491-497. PubMed ID: 35254922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy.
    Garciaz S; Harel S; Amorim S; Bouabdallah R; Thieblemont C; Brice P
    Br J Haematol; 2016 Nov; 175(4):735-737. PubMed ID: 26685097
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiokeratoma corporis diffusum in a patient with Hodgkin lymphoma: a new paraneoplastic skin manifestation?
    Han F; Wang P; Li Z; Zheng JH; Wang Q; Xu AE; Wang ZM
    Br J Dermatol; 2013 Jun; 168(6):1351-3. PubMed ID: 23278357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.